Qi deng
Academic / Other · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma Lymphoma, CAR T Cell Therapy, Acute Leukemia | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders Plasma Cell Dyscrasias | EARLY_Phase 1 | 2026-01-25 |
| Not Yet Recruiting | CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia CD7+ Lymphoma, CD7+ Acute Leukemia | N/A | 2025-06-01 |